Glympse Bio
Scott Friedman is on the Board of Advisors at Glympse Bio. Scott is also Chief in the Division of Liver Diseases at Icahn School of Medicine, Mt. Sinai.
This person is not in the org chart
This person is not in any offices
Glympse Bio
Glympse Bio is pioneering the development of synthetic biomarkers – biological sensors developed using breakthroughs in science, engineering, medicine and artificial intelligence – that are bioengineered to be perfectly tunable to any disease, absolutely specific, and offer earlier measures of response to disease and treatment.